Get started
Author

Rudy Foddis

Observed names: Foddis R., Foddis Rudy, Foddis, R., R Foddis, R. Foddis, R.� Foddis, RUDY FODDIS, Rudy FODDIS, Rudy Foddis (511645)
Institution: University of Pisa
Observed institutions: Università Cattolica del Sacro Cuore, University of Pisa, Loyola University Chicago, University of Trento, Ospedale Cisanello, Azienda Ospedaliera Universitaria Pisana, Regione Toscana
ORCID: 0000-0003-1330-3863
Observed ORCID: 0000-0003-1330-3863
OpenAlex ID: A5080431908
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses
2020 · Alessandro Antonelli, Silvia Martina Ferrari, et al. · Best Practice & Research Clinical Endocrinology & Metabolism · 264
Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung Cancer
2007 · Alfonso Cristaudo, Rudy Foddis, et al. · Clinical Cancer Research · 164
Mental health of Health Care Workers (HCWs): a review of organizational interventions put in place by local institutions to cope with new psychosocial challenges resulting from COVID-19
2021 · Rodolfo Buselli, Martina Corsi, et al. · Psychiatry Research · 157
SV40 infection induces telomerase activity in human mesothelial cells
2002 · Rudy Foddis, Assunta De Rienzo, et al. · Oncogene · 118
SV40 Enhances the Risk of Malignant Mesothelioma among People Exposed to Asbestos: A Molecular Epidemiologic Case-Control Study
2005 · Alfonso Cristaudo, Rudy Foddis, et al. · Cancer Research · 98
SV40 and the pathogenesis of mesothelioma
2001 · Paola Rizzo, Maurizio Bocchetta, et al. · Seminars in Cancer Biology · 73
Combined Serum Mesothelin and Plasma Osteopontin Measurements in Malignant Pleural Mesothelioma
2011 · Alfonso Cristaudo, Alessandra Bonotti, et al. · Journal of Thoracic Oncology · 64
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism
2017 · Chiara De Santi, Ombretta Melaiu, et al. · Scientific Reports · 60
PDF
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma
2011 · Ombretta Melaiu, Alfonso Cristaudo, et al. · Mutation Research/Reviews in Mutation Research · 60
Comparison between Plasma and Serum Osteopontin Levels: Usefulness in Diagnosis of Epithelial Malignant Pleural Mesothelioma
2010 · Alfonso Cristaudo, Rudy Foddis, et al. · The International Journal of Biological Markers · 49
PDF
Evaluation of Flu Vaccination Coverage among Healthcare Workers during a 3 Years’ Study Period and Attitude towards Influenza and Potential COVID-19 Vaccination in the Context of the Pandemic
2021 · Giuditta Scardina, Luca Ceccarelli, et al. · Vaccines · 44
Expression status of candidate genes in mesothelioma tissues and cell lines
2014 · Ombretta Melaiu, Erika Melissari, et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 38
PDF
MSLN Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma
2014 · Ombretta Melaiu, Justin Stebbing, et al. · PLoS ONE · 37
PDF
Serum mesothelin and other biomarkers: what have we learned in the last decade?
2018 · Alfonso Cristaudo, Alessandra Bonotti, et al. · Journal of Thoracic Disease · 36
PDF
Serum Mesothelin, Osteopontin and Vimentin: Useful Markers for Clinical Monitoring of Malignant Pleural Mesothelioma
2016 · Alessandra Bonotti, Silvia Simonini, et al. · The International Journal of Biological Markers · 30
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin
2020 · Poupak Fallahi, Silvia Martina Ferrari, et al. · Seminars in Cancer Biology · 27
A Novel Panel of Serum Biomarkers for MPM Diagnosis
2017 · A. Bonotti, R. Foddis, et al. · Disease Markers · 27
PDF
ChatGPT in Occupational Medicine: A Comparative Study with Human Experts
2024 · Martina Padovan, Bianca Cosci, et al. · Bioengineering · 25
PDF
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
2017 · Ombretta Melaiu, Calogerina Catalano, et al. · Genes & Cancer · 24
PDF
Soluble Markers for Diagnosis of Malignant Pleural Mesothelioma
2011 · Alfonso Cristaudo, Alessandra Bonotti, et al. · Biomarkers in Medicine · 23
Medical surveillance of workers previously exposed to asbestos.
2007 · A Cristaudo, R Foddis, et al. · PubMed · 22
Comparative proteomic analysis of malignant pleural mesothelioma evidences an altered expression of nuclear lamin and filament‐related proteins
2014 · Laura Giusti, Ylenia Da Valle, et al. · PROTEOMICS - CLINICAL APPLICATIONS · 21
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer
2022 · Francesca Ragusa, Silvia Martina Ferrari, et al. · International Journal of Molecular Sciences · 20
PDF
Irritable Bowel Syndrome prevalence and work ability in a sample of healthcare workers exposed to occupational stress
2021 · Rodolfo Buselli, Antonello Veltri, et al. · Journal of Psychosomatic Research · 20
Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome
2020 · SERENA LACERENZA, FEDERICA CIREGIA, et al. · Cancer Genomics & Proteomics · 20
PDF
Works count: 150
Citation count: 1,890
H-index: 21
I10-index: 35
Year
Topic
Type